|
 rumisong rated 22 months ago - From the page: "Scientists find way to slash cost of drugs
Indian-backed approach could aid poor nations and cut NHS bills
Sarah Boseley, health editor
Tuesday January 2, 2007
The Guardian
Two UK-based academics have devised a way to invent new medicines and get them to market at a...
|
|
4 Reviews
-
-
- parvez rated 20 months ago
- From the page: "Scientists find way to slash cost of drugs
"
 voice-of-reason rated 21 months ago- It takes a lot of effort and expense to develop a new drug. This approach is as subtle as filed off serial numbers on a stolen car. Instead we should figure out ways to genuinely reduce the cost of drug development. It would help if drug companies could spend less on marketing. Also if clinical trials could be made smaller and less expensive -- which probably means letting go of the idea of blockbuster drugs, and focusing instead on a portfolio of drugs and diagnoses, and re-examining the criteria for proof of effect.
- rumisong rated 22 months ago
- From the page: "Scientists find way to slash cost of drugs
Indian-backed approach could aid poor nations and cut NHS bills
Sarah Boseley, health editor
Tuesday January 2, 2007
The Guardian
Two UK-based academics have devised a way to invent new medicines and get them to market at a fraction of the cost charged by big drug companies, enabling millions in poor countries to be cured of infectious diseases and potentially slashing the NHS drugs bill.
Sunil Shaunak, professor of infectious diseases at Imperial College, based at Hammersmith hospital, calls their revolutionary new model "ethical pharmaceuticals".
Improvements they devise to the molecular structure of an existing, expensive drug turn it technically into a new medicine which is no longer under a 20-year patent to a multinational drug company and can be made and sold cheaply."
- Septembre rated 22 months ago
- From the page: "Sunil Shaunak, professor of infectious diseases at Imperial College, based at Hammersmith hospital, calls their revolutionary new model "ethical pharmaceuticals".
Improvements they devise to the molecular structure of an existing, expensive drug turn it technically into a new medicine which is no longer under a 20-year patent to a multinational drug company and can be made and sold cheaply.
The process has the potential to undermine the monopoly of the big drug companies and bring cheaper drugs not only to poor countries but back to the UK."
|
